Felice Petraglia

No ORCID on file · 279 papers in corpus · active 2002-2026

Study types

  • article 157
  • review 42
  • dataset 32
  • other 28
  • book-chapter 9

Condition tags

  • endometriosis 191
  • mesh:D004715 110
  • adenomyosis 78
  • infertility 48
  • dysmenorrhea 40
  • die_deep_infiltrating 28
  • dyspareunia 25
  • mesh:D017699 17
  • endometrioma 17
  • chronic_pelvic_pain 16
rct
Lancet (London, England) ·doi:10.1016/S0140-6736(22)01475-1

BACKGROUND: Uterine fibroids are common non-cancerous neoplasm that cause heavy menstrual bleeding and other signs. Linzagolix is an oral gonadotropin-releasing hormone receptor antagonist taken once per day that dose-dependently suppresses…

article 2026
·doi:10.1016/j.jeud.2026.100153

• Adenomyosis shows a strong association with heavy menstrual bleeding. • Endometriosis is linked to more severe pain-related symptoms than adenomyosis. • Dyspareunia is common in both conditions and lacks discriminatory value. • Coexistenc…

other 2026
F&S science ·doi:10.1016/j.xfss.2026.03.001

OBJECTIVE: To assess the prevalence of proliferative endometrial disorders in women with histologically confirmed adenomyosis and to evaluate the independent association between adenomyosis and each lesion type. DESIGN: Retrospective cohor…

article 2026
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2026.105642

Endometriosis is a chronic, systemic, oestrogen-dependent disease with major impacts on pain, fertility and quality of life. This Society of Endometriosis and Uterine Disorders and American Institute for Minimally Invasive Surgery opinion s…

review 2026
Trends in molecular medicine ·doi:10.1016/j.molmed.2025.09.002

Endometriosis, traditionally viewed as a gynecological condition, is increasingly recognized as a systemic disease due to its frequent association with inflammatory and autoimmune comorbidities. Recent molecular and genetic insights reveal …

other 2026
Human reproduction open ·doi:10.1093/hropen/hoag030

STUDY QUESTION: Was the efficacy of linzagolix, observed at 6 months in women with endometriosis-associated pain, maintained when administered for an additional 6 months? SUMMARY ANSWER: Efficacy from this extension study complements the r…

article 2026
·doi:10.3390/ijms27104598

Ovarian endometriosis (OE) is a chronic, inflammatory gynecological disorder associated with sterility and an elevated risk of ovarian cancer. Despite its high prevalence, the complex molecular mechanisms governing OE pathogenesis remain po…

other 2026
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2026.114950

BACKGROUND: Endometriosis is a chronic endocrine and inflammatory disease commonly presenting with dysmenorrhea, pelvic pain, and/or infertility. Despite the importance of menstrual symptoms, the impact of menstruation on stress is still po…

article 2026
·doi:10.1097/j.pain.0000000000004016

ABSTRACT: Pain is influenced by a complex interplay of biological, psychological, and social factors. Sex has emerged as a key determinant of vulnerability to chronic pain and a major risk factor for poor response to available pharmacologic…

book-chapter 2026
·doi:10.1016/b978-0-443-13825-6.00312-5
other 2025
Gynecologic oncology ·doi:10.1016/j.ygyno.2025.02.017

BACKGROUND/OBJECTIVE: Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation b…

other 2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1697567

Autoimmune and inflammatory rheumatic diseases (RDs) are more prevalent in women and often affect gynecological health. Particularly, heavy menstrual bleeding (HMB) and dysmenorrhea are more common in patients with RD. A link between RDs an…

review 2025
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.104837

Adenomyosis, a menstruation-related uterine disorder, refers to the presence of endometrial stroma and glands within the myometrium and is typically observed in reproductive-age women. The pathogenesis explaining the migration, persistence,…

other 2025
Cellular signalling ·doi:10.1016/j.cellsig.2025.111876

Endometriosis is a chronic inflammatory disease characterized by the invasion of endometrial cells outside the uterine cavity. Current treatments for the disease, whose typical symptoms are pain and infertility, are unsatisfactory, relying …

review 2025
Current obesity reports ·doi:10.1007/s13679-025-00662-8

PURPOSE OF THE REVIEW: This review aimed to summarize current evidence on the effectiveness of medical nutrition therapy (MNT) in the management of obesity and endometriosis, with a focus on dietary patterns such as the Mediterranean and Ke…

article 2025
·doi:10.1016/j.jeud.2025.100135

• Endometriosis and fibromyalgia frequently co-occur, even though in more than two-thirds of cases, the diagnosis of endometriosis preceded that of fibromyalgia. • Patients with endometriosis and fibromyalgia exhibit distinct clinical chara…

article 2025
·doi:10.22541/au.175795219.98019669/v1

not-yet-known not-yet-known not-yet-known unknown Background. Ovarian endometriosis is a persistent inflammatory disease characterized by the atypical presence of stroma and endometrial-like glands within the ovaries, often leading to steri…

other 2025
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70079

PROBLEM: Immunological abnormalities are well recognized in the pathogenesis of endometriosis and the co-existence of endometriosis with inflammatory bowel disease (IBD) and celiac disease (CD), along with other systemic immune disorders, i…

other 2025
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2025.102963

BACKGROUND: Pudendal neuralgia caused by entrapment syndrome (PNE) is an underdiagnosed condition with severe quality of life (QoL) impact. In cases unresponsive to medical treatment, a minimally invasive surgical approach, such as laparosc…

rct 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.06.016

OBJECTIVE: To evaluate whether oral linzagolix administered once daily for up to 52 weeks (extension study) at a dose of 100 mg or 200 mg with or without hormonal add-back therapy (ABT) (1.0 mg estradiol; 0.5 mg norethisterone acetate) can …

article 2025
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2025.2511329

BACKGROUND: Adenomyosis is a uterine disorder causing menstruation-related symptoms such as dysmenorrhea, heavy menstrual bleeding (HMB) and dyspareunia. A long-term management of the disease is required. Hormonal drugs are the most used, i…

other 2025
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.202502415R

Endometriosis is a chronic inflammatory disease characterized by the ectopic implantation of endometrium outside the uterus associated with pelvic pain and infertility. The molecular mechanisms involved in the pathogenesis of endometriosis …

review 2025
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2025.2451145

INTRODUCTION: Dysmenorrhea is a painful symptom associated with uterine contractions and menstrual bleeding and is treated by administering analgesic drugs. Since progesterone receptors (PRs) have a major role in regulating uterine tissues …

other 2025
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.105102

RESEARCH QUESTION: How do comorbidities and their prevalence differ between patients with adenomyosis alone and patients with both adenomyosis and endometriosis? DESIGN: A prospective observational study compared the presence of comorbidit…

review 2025
European journal of endocrinology ·doi:10.1093/ejendo/lvaf192

Endometriosis is a chronic gynecologic disease of reproductive-age women, causing menstrual pain and infertility. Endocrine and inflammatory mechanisms drive its development, with estrogen/progesterone imbalance contributing to extrauterine…